Literature DB >> 15365822

p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan.

For-Wey Lung1, Tai-Min Lee, Bih-Ching Shu, Fu-Hsin Chang.   

Abstract

PURPOSE: The p53 tumor suppressor gene plays two important roles in genomic stability: blocking cell proliferation after DNA damage until it has been repaired, and starting apoptosis if the damage is too critical. A recent report suggests that a polymorphism of the p53 tumor suppressor gene that results in the substitution of a proline residue with an arginine residue at position 72 of the p53 protein might act as a risk factor in the malignant transformation of colorectal adenoma to cancer.
METHODS: In our study, the samples consisted of 150 patients were analyzed for the mutation in the p53 gene. The age of 150 patients (46 women and 104 men) ranged from 30 to 91 years (mean age 68.46 years).
RESULTS: The polymorphism showed 52.04% mutant in the codon 72 of exon 4 in the Taiwanese population. Both of the chi-square for trend test (chi-square = 4.97, p = 0.034) and logistic regression (p = 0.037, odds ratio = 1.699) showed significant differences in the distribution of polymorphism of codon 72 in the p53 gene and Dukes classification of colorectal cancer.
CONCLUSIONS: There were significant relationship between the polymorphism of codon 72 and the malignancy of colorectal cancer in Taiwanese population. There is 1.70 times in each grade change (Dukes A-D) more risk of CCC polymorphism than that of CCG polymorphism of codon 72 of exon 4.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365822     DOI: 10.1007/s00432-004-0605-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Cancer. A deadly inheritance.

Authors:  B Vogelstein
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

2.  The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.

Authors:  R E Buller; A Sood; C Fullenkamp; J Sorosky; K Powills; B Anderson
Journal:  Cancer Gene Ther       Date:  1997 Jul-Aug       Impact factor: 5.987

3.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Molecular basis for heterogeneity of the human p53 protein.

Authors:  N Harris; E Brill; O Shohat; M Prokocimer; D Wolf; N Arai; V Rotter
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

5.  Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

Authors:  A Storey; M Thomas; A Kalita; C Harwood; D Gardiol; F Mantovani; J Breuer; I M Leigh; G Matlashewski; L Banks
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

6.  Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.

Authors:  U Lindforss; H Fredholm; N Papadogiannakis; A Gad; H Zetterquist; H Olivecrona
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

7.  Primary structure polymorphism at amino acid residue 72 of human p53.

Authors:  G J Matlashewski; S Tuck; D Pim; P Lamb; J Schneider; L V Crawford
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

8.  Clonal analysis of human colorectal tumors.

Authors:  E R Fearon; S R Hamilton; B Vogelstein
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

9.  p53 polymorphisms and haplotypes in breast cancer.

Authors:  A Själander; R Birgander; G Hallmans; S Cajander; P Lenner; L Athlin; G Beckman; L Beckman
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

10.  p53 codon 72 polymorphism and risk of cervical cancer in UK.

Authors:  A N Rosenthal; A Ryan; R M Al-Jehani; A Storey; C A Harwood; I J Jacobs
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

View more
  14 in total

1.  Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.

Authors:  Upender Manne; Trafina Jadhav; Balananda-Dhurjati Kumar Putcha; Temesgen Samuel; Shivani Soni; Chandrakumar Shanmugam; Esther A Suswam
Journal:  Curr Colorectal Cancer Rep       Date:  2016-09-20

Review 2.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Jing-Jun Wang; Yuan Zheng; Liang Sun; Li Wang; Peng-Bo Yu; Jian-Hua Dong; Lei Zhang; Jing Xu; Wei Shi; Yu-Chun Ren
Journal:  Mol Biol Rep       Date:  2010-12-08       Impact factor: 2.316

4.  Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.

Authors:  For-Wey Lung; Bih-Ching Shu; Wei-Tsung Kao; C Nathan Chen; Yu-Chi Ku; Dong-Sheng Tzeng
Journal:  BMC Med Genet       Date:  2009-12-29       Impact factor: 2.103

5.  Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina.

Authors:  Luis Orlando Pérez; Martin Carlos Abba; Fernando Noel Dulout; Carlos Daniel Golijow
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

6.  Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chandrakumar Shanmugam; Wen Wan; Sreelatha Meleth; Harvey Bumpers; William E Grizzle; Upender Manne
Journal:  Clin Cancer Res       Date:  2009-04-01       Impact factor: 12.531

7.  p53 codon 72 polymorphism as a progression index for bladder cancer.

Authors:  Hung-Yu Lin; Chun-Hsiung Huang; Tsan-Jung Yu; Wen-Jen Wu; Ming-Chang Yang; For-Wey Lung
Journal:  Oncol Rep       Date:  2011-12-22       Impact factor: 3.906

8.  Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis.

Authors:  Santhi Latha Pandrangi; Sarangadhara Appala Raju Bagadi; Navin Kumar Sinha; Manoj Kumar; Rima Dada; Meena Lakhanpal; Abha Soni; Shreshtha Malvia; Sheeba Simon; Chintamani Chintamani; Ravindar Singh Mohil; Dinesh Bhatnagar; Sunita Saxena
Journal:  Cancer Cell Int       Date:  2014-02-05       Impact factor: 5.722

9.  Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir.

Authors:  Arshad A Pandith; Nighat P Khan; Nargis Rashid; Niyaz Azad; Inam Zaroo; Adil Hafiz; Mushtaq A Siddiqi
Journal:  Tumour Biol       Date:  2012-01-17

10.  TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses.

Authors:  Hung-Yu Lin; Chun-Hsiung Huang; Wen-Jen Wu; Li-Ching Chang; For-Wey Lung
Journal:  Int J Biomed Sci       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.